The EU did a Brexit trade deal with the pharma industry: it tried to lock in a perceived short-term price advantage at the expense of everything else. Instead of prioritising the speed and security of supplies at any price, the EU prioritised the price. The EU paid 24% less for the Pfizer vaccine than the US, for example. For the Oxford/AstraZeneca vaccine, the price gap is 45%. The UK almost certainly paid a lot more. It is no wonder that the manufacturers are prioritising orders on a first-come, first-serve basis, and from countries that pay the full price. The price difference is macroeconomically irrelevant. But if vaccine shortages lead to longer lockdowns, the indirect effect of that short-sighted policy will be massive.
Related Articles

EU politics
Fintan O’Toole: The hard-won kinship between Britain and Ireland is threatened by Brexit idiocy
Few understand, or care about for that matter, the existential question concerning the reintroduction of a hard border between Ireland the Northern Ireland. The Irish fear that the EU is selling them down the river […]

Austerity
Bill Mitchell: Greece “neither thrived nor struggled” – the financial press alt world
December 31, 2018
Mathew D. Rose
Austerity, EU politics, EU-Institutions, Inequality, National Politics, Neo-Liberalism in the EU
0
One thing has not changed during 2018: the neo-liberal propaganda of European state and commerical media. Read here

EU politics
Bloomberg: Julian Assange Tells Court He Won’t ‘Surrender to America’
The WikiLeaks founder says he does not wish to surrender to extradition for doing ‘journalism that has won many awards’. Read here
Be the first to comment